1. Home
  2. TAP vs ARWR Comparison

TAP vs ARWR Comparison

Compare TAP & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Molson Coors Beverage Company Class B

TAP

Molson Coors Beverage Company Class B

HOLD

Current Price

$42.60

Market Cap

10.1B

ML Signal

HOLD

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$57.70

Market Cap

10.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAP
ARWR
Founded
1873
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
10.1B
IPO Year
N/A
2009

Fundamental Metrics

Financial Performance
Metric
TAP
ARWR
Price
$42.60
$57.70
Analyst Decision
Hold
Strong Buy
Analyst Count
16
10
Target Price
$50.31
$81.50
AVG Volume (30 Days)
2.9M
1.8M
Earning Date
01-01-0001
05-08-2026
Dividend Yield
4.53%
N/A
EPS Growth
N/A
99.80
EPS
N/A
0.22
Revenue
N/A
$16,142,321.00
Revenue This Year
$0.85
N/A
Revenue Next Year
$0.14
N/A
P/E Ratio
N/A
$263.00
Revenue Growth
N/A
N/A
52 Week Low
$42.08
$10.66
52 Week High
$63.40
$76.76

Technical Indicators

Market Signals
Indicator
TAP
ARWR
Relative Strength Index (RSI) 28.89 39.72
Support Level N/A $36.34
Resistance Level $47.36 $66.37
Average True Range (ATR) 1.10 2.97
MACD -0.61 -0.53
Stochastic Oscillator 7.09 28.03

Price Performance

Historical Comparison
TAP
ARWR

About TAP Molson Coors Beverage Company Class B

Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling and ranks as the second-largest beer maker in both value and volume terms in the US, Canada, and the United Kingdom. Through licensing agreements, the firm also brews and distributes beer and hard seltzer under partner brands from Heineken, Anheuser-Busch InBev, Asahi, and Coca-Cola. The brewer uses independent distributors in the US, given the three-tier distribution requirements, while using a combination of distributors and an in-house sales team in Canada and Europe. North America remains its largest market, contributing over 80% of total revenue.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

Share on Social Networks: